Osteopontin Upregulates the Expression of Glucose Transporters in Osteosarcoma Cells

Glucose transporters in cancer metabolism

(2012) Kehinde Adekola et al.   CURRENT OPINION IN ONCOLOGY

What’s New in Primary Bone Tumors

(2012) Joseph H. Schwab et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Osteopontin: a potentially important therapeutic target in cancer

(2011) Mansoor Ahmed et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer Progression

(2011) T. M. Tilli et al.   MOLECULAR CANCER RESEARCH

Osteopontin is a marker for cancer aggressiveness and patient survival

(2010) G F Weber et al.   BRITISH JOURNAL OF CANCER

Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer

(2010) Tomomi Egawa-Takata et al.   CANCER SCIENCE

Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling

(2010) S. Rey et al.   CARDIOVASCULAR RESEARCH

HIF-1: upstream and downstream of cancer metabolism

(2009) Gregg L Semenza   CURRENT OPINION IN GENETICS & DEVELOPMENT

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

The role of hypoxia-inducible factors in tumorigenesis

(2008) E B Rankin et al.   CELL DEATH AND DIFFERENTIATION

In vitroandin vivostudy of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter

(2008) Chih-Hsiung Wu et al.   INTERNATIONAL JOURNAL OF CANCER

Epithelioid osteosarcoma of the mandible: a rare case with unusual immunoprofile

(2008) Román Carlos-Bregni et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS